S UPPLEMENTARY F IGURES
Supplementary Figure 1: Number of prioritized and linked cases and percent increase for each cluster prioritization scheme for years 2016/2017. Note that the number of individuals prioritized in the cluster growth schemes is determined by the number of individuals in category RR3 (n≈150). Cluster
prioritization schemes are defined in Table 1.
Supplementary Figure 2: Sensitivity Analysis. Number of prioritized and linked cases and percent increase for each cluster prioritization scheme for years (A.) 2014/2015, (B.) 2015/2016 and (C.) 2015/2016. The number of individuals prioritized in the cluster growth schemes is determined by the number of
individuals in category RR2 (n≈250), instead of in RR3 (n≈150). Cluster prioritization schemes are defined in Table 1.
Supplementary Figures 3-12: Genetic networks for the year 2015 under every cluster definition in Table 1, showing the breakdown by A. Race/ethnicity, B. Transmission risk group, C. Age group and D. Date of diagnosis. The year 2015 was chosen for consistency with Table 2.
c1.5% c1% c0.5% g1.5% g1% g0.5% RR2 RR3 RR4 RR5
Number of pr ior itiz ed cases (2016) and link ed cases (2017)
● ● ● ● ● ● ● ● ● ●
0%20%40%60%80%100%120%
030070011001600210026003100
P ercent increase
Clustering Square root relative growth
Recent and rapid growth
(minimum # in last year)
c1.5% c1% c0.5% g1.5% g1% g0.5% RR2 RR3 RR4 RR5
A. 2014/2015
Number of prioritized cases (2014) and linked cases (2015)
●
● ●
●
●
●
●
● ●
●
0%20%40%60%80%100%120%
0200500800110014001700
P ercent increase
Clustering Square root
relative growth
Recent and rapid growth (minimum # in last year)
c1.5% c1% c0.5% g1.5% g1% g0.5% RR2 RR3 RR4 RR5
B. 2015/2016
Number of prioritized cases (2015) and linked cases (2016)
●
● ●
●
● ● ●
● ● ●
0%20%40%60%80%100%120%
03006009001300170021002500
P ercent increase
Clustering Square root
relative growth
Recent and rapid growth (minimum # in last year)
c1.5% c1% c0.5% g1.5% g1% g0.5% RR2 RR3 RR4 RR5
C. 2016/2017
Number of prioritized cases (2016) and linked cases (2017)
● ● ● ● ● ● ● ● ● ●
0%20%40%60%80%100%120%
030070012001700220027003200
P ercent increase
Clustering Square root
relative growth
Recent and rapid growth (minimum # in last year)
● ●
●
● ●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
Black White Latino other/NA
● ●
●
● ●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
MSM PWID HET MSM/IDU other/NA
C. Age group
● ●
●
● ●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
14−19 20−24 25−29 30−39 40−49 50−100 NA
D. Date of diagnosis
● ●
●
● ●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
pre−2015 2015
A. Race/ethnicity
●
Black ●
White Latino other/NA
B. Transmission risk group
●
MSM ●
PWID HET MSM/IDU other/NA
C. Age group
●
14−19 ●
20−24 25−29 30−39 40−49 50−100 NA
D. Date of diagnosis
●
pre−2015 ●
2015
Supplementary Figure 4: High relative cluster growth at 1.5% (g1.5%) (2015)
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
● ●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
● ●
● ●
●
●
●
●
● ●
● ●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
Black White Latino other/NA
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
● ●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
● ●
● ●
●
●
●
●
● ●
● ●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
MSM PWID HET MSM/IDU other/NA
C. Age group
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
● ●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
● ●
● ●
●
●
●
●
● ●
● ●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
14−19 20−24 25−29 30−39 40−49 50−100 NA
D. Date of diagnosis
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
● ●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
● ●
● ●
●
●
●
●
● ●
● ●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
pre−2015 2015
A. Race/ethnicity
●
Black White Latino other/NA
B. Transmission risk group
●
MSM PWID HET MSM/IDU other/NA
C. Age group
●
14−19 20−24 25−29 30−39 40−49 50−100 NA
D. Date of diagnosis
●
pre−2015 2015
Supplementary Figure 6: High relative cluster growth at 1% (g1%) (2015)
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
Black White Latino other/NA
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
MSM PWID HET MSM/IDU other/NA
C. Age group
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
14−19 20−24 25−29 30−39 40−49 50−100 NA
D. Date of diagnosis
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●
●
●
●
● ●
●
●
●
●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
pre−2015 2015
A. Race/ethnicity
●
●
Black White Latino other/NA
B. Transmission risk group
●
●
MSM PWID HET MSM/IDU other/NA
C. Age group
●
●
14−19 20−24 25−29 30−39 40−49 50−100 NA
D. Date of diagnosis
●
●
pre−2015 2015
Supplementary Figure 8: High relative cluster growth at 0.5% (g0.5%) (2015)
●●
●
●●
●
●
●
●
●
●
●
Black White Latino other/NA
●●
●
●●
●
●
●
●
●
●
●
MSM PWID HET MSM/IDU other/NA
C. Age group
●●
●
●●
●
●
●
●
●
●
●
14−19 20−24 25−29 30−39 40−49 50−100 NA
D. Date of diagnosis
●●
●
●●
●
●
●
●
●
●
●
pre−2015 2015
A. Race/ethnicity
●
●
●
Black White Latino other/NA
B. Transmission risk group
●
●
●
MSM PWID HET MSM/IDU other/NA
C. Age group
●
●
●
14−19 20−24 25−29 30−39 40−49 50−100 NA
D. Date of diagnosis
●
●
●
pre−2015 2015
Supplementary Figure 10: Recent and rapid, min 3 diagnoses in most recent year (RR3) (2015)
●
Black White Latino other/NA
●
MSM PWID HET MSM/IDU other/NA
C. Age group
●
14−19 20−24 25−29 30−39 40−49 50−100 NA
D. Date of diagnosis
●
pre−2015 2015
A. Race/ethnicity
●
Black White Latino other/NA
B. Transmission risk group
●
MSM PWID HET MSM/IDU other/NA
C. Age group
●
14−19 20−24 25−29 30−39 40−49 50−100 NA
D. Date of diagnosis
●
pre−2015 2015
Supplementary Figure 12: Recent and rapid, min 5 diagnoses in most recent year (RR5) (2015)
